reference/6716407

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6716407

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	37139
issn	1949-2553
issueIdentifier	23
pageRange	37128-37139
publicationName	Oncotarget
startingPage	37128
bibliographicCitation	Chen Y, You F, Jiang L, Li J, Zhu X, Bao Y, Sun X, Tang X, Meng H, An G, Zhang B, Yang L. Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody. Oncotarget. 2017 Jun 06;8(23):37128–39. PMID: 28415754; PMCID: PMC5514896.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d41247f31b1ed9b7640a2eb567bd118d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6417ad3709e8f78ba77b9c866234ca0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21f8f6fa89453a6218b1f5221d595e3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8cdc9754e06ab404b2f5d75837c526a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ed7e1a088e2edcc47f7ef2fe6316c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a93d59c4cc995853e01118da97315a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c9963fdb9639373e26e6cae3762c59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c11add7f7c8a71d37b234dcca07caac4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4927a2089bc11c923e2b67a19e875d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1d3e946c42697d09e5612aa530086d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a063901e9a5340ea04bd7d48d58fa9e4
date	2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5514896 https://doi.org/10.18632/oncotarget.16201 https://pubmed.ncbi.nlm.nih.gov/28415754
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803 https://portal.issn.org/resource/ISSN/1949-2553
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody
discusses	http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0026482 http://id.nlm.nih.gov/mesh/M0028321 http://id.nlm.nih.gov/mesh/M000626416 http://id.nlm.nih.gov/mesh/M0018640
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017452Q000276 http://id.nlm.nih.gov/mesh/D011993Q000276 http://id.nlm.nih.gov/mesh/D000920Q000276 http://id.nlm.nih.gov/mesh/D007694Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017452Q000235 http://id.nlm.nih.gov/mesh/D018951Q000276 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D000069283Q000494 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D000074322Q000494 http://id.nlm.nih.gov/mesh/D011993Q000235 http://id.nlm.nih.gov/mesh/D020014 http://id.nlm.nih.gov/mesh/D000069283Q000276 http://id.nlm.nih.gov/mesh/D000920Q000187 http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D000074322Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020522Q000473 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D011993Q000378 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D002470Q000276 http://id.nlm.nih.gov/mesh/D018951Q000378 http://id.nlm.nih.gov/mesh/D020522Q000188 http://id.nlm.nih.gov/mesh/D020522Q000276 http://id.nlm.nih.gov/mesh/D016688 http://id.nlm.nih.gov/mesh/D007694Q000378 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D017452Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9980c80e7356170286922c7957cbd5f9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fc3ca99a9eadb7f217b27a7cbb148e96 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3ad2119464233024868ba3753ac34390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9a784dff46ed44d6c0b5f4ad7f906f62 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2bd07a19b5756264ad211f430a592075 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b417e023e679477b7a58dd6b19d2a8b5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c39dfa3c98491d25b749b54f8cf226ff http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d180f13a3f81bf5e3d1904187dad811f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33

Total number of triples: 77.